Bonded Phase Application Area USP Listing Particle Size (µm) Pore Size (Å) pH Range Temp. Max °C
(low pH)
Temp. Max °C
(high pH)
Carbon Load (%) Surface Area (m2/g) Endcapped Buy
SEC Proprietary Diol - 120
  • Small Molecule Drugs
  • Heparin
  • Peptides
  • Glycans
  • Small Oligonucleotides
L33

1.8
3
5

120

2-8 40 40

Proprietary

Proprietary

Proprietary Buy Now
SEC Proprietary Diol - 150
  • Small Molecule Drugs
  • Heparin
  • Peptides
  • Glycans
  • Small Oligonucleotides
  • Small Proteins
L33

1.8
3
5

120

2-8 40 40

Proprietary

Proprietary

Proprietary Buy Now
SEC Proprietary Diol - 300
  • mAbs and aggregates
L59

1.8
3
5

300

2-8 40 40

Proprietary

Proprietary

Proprietary Buy Now
SEC Proprietary Diol - 500
  • mAbs
  • High-order Aggregates
  • Large Proteins
  • Small DNA/RNA
L59

1.8
3
5

500

2-8 40 40

Proprietary

Proprietary

Proprietary Buy Now
SEC Proprietary Diol - 1000
  • Aggregates and Fragments Analysis in mRNAs
  • Aggregates and fragments Analysis in Plasmids
L59

3

1000

2-8 40 40

Proprietary

Proprietary

Proprietary Buy Now

Additional Details

  • Innovative Monodisperse Particle Technology platform
  • Monodisperse platform allows high N, high mechanical strength, and high pore volume – which delivers high Rs
  • Advanced column chemistry throughout particle size and pore size range to minimize secondary interactions
  • Monodisperse platform inherently delivers excellent batch to batch reproducibility
  • Excellent column to column consistency